Cholesterol & Lipid
Sort by:
Stephen Kopecky
CV Outcomes Trials with PCSK9 Inhibitors – SPIRE, ODYSSEY, FOURIER and EBBINGHAUS
- 749 views
- August 18, 2017
- 2
Michael Shapiro
Current Challenges in Lipid Lowering Therapy and Prevention of ASCVD
- 980 views
- August 18, 2017
- 5
Michael Ozner
The IMPROVE-IT Trial: Lessons Learned and Clinical Implications
- 650 views
- September 15, 2017
New Cardiovascular Horizons (NCVH) 2017
Role of Statins and PCSK9 Inhibitors
FEATURING
Craig Walker
- 566 views
- September 18, 2017
- 2
New Cardiovascular Horizons (NCVH) 2017
Diet Management and Lipid Management LP(a)
FEATURING
Michael Ledet
- 268 views
- September 19, 2017
Cardiovascular Disease Management - 5th Annual Symposium
Statins are Way Underused… and it’s Killing Americans
FEATURING
Dinesh Kalra
- 828 views
- December 27, 2017
- 6
Cardiovascular Disease Management - 5th Annual Symposium
Can Heart Disease Eventually be Abolished? The PCSK9 Revolution
- 782 views
- December 27, 2017
- 1
IRRIV International Renal Research Institute Vicenza
Ongoing CV Trials in Kidney Patients
FEATURING
Claudio Ronco
- 175 views
- February 6, 2018
The American Society for Preventive Cardiology
PCSK9 Inhibitors: Access Barriers Affect Real People
- 52 views
- March 20, 2018
The American Society for Preventive Cardiology
Accessing Breakthrough Cholesterol Treatments
FEATURING
Seth Baum
- 326 views
- March 20, 2018
- 1
Cardiometabolic Health Congress (CMHC)
Best Practices: Effective Management of the Authorization Process for PCSK9
FEATURING
Pamela Morris
- 251 views
- May 7, 2018
- 1
Cardiometabolic Health Congress (CMHC)
Strategies and Resources to Support the PCSK9 Authorization Process
FEATURING
Kim Birtcher
- 56 views
- May 7, 2018